FindMyRecallSubscribe
Class III: unlikely to cause harmOngoing

Supernus Pharmaceuticals Trokendi XR Recall

Trokendi XR, topiramate extended-release capsules, 25mg, 30 Capsules, Rx only, Manufact…

Supernus Pharmaceuticals, Inc. · Rockville, MD

Risk level
Class III
Reported by FDA
Jul 29, 2026
Recall ID
D-0758-2026
Check your lot numberHow we source this data

Summary

Supernus Pharmaceuticals recalled Trokendi XR starting Jul 6, 2026. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-0758-2026 on Jul 29, 2026. Reason: Failed Dissolution Specifications. Status: Ongoing.

Why it was recalled

Failed Dissolution Specifications

Product description

Trokendi XR, topiramate extended-release capsules, 25mg, 30 Capsules, Rx only, Manufactured by: Catalent Pharma Solutions, Winchester, KY 40391 USA, Manufactured for: Supernus Pharmaceuticals, Inc., Rockville, MD 20850 USA, NDC 17772-101-30.

Lot numbers, UPCs & expiration codes

Lot # 2075801, Exp Date: 31-Oct-2029.

Where it was sold

US Nationwide.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0758-2026
Classification
Class III
Status
Ongoing
Recall initiated
Jul 6, 2026
FDA report date
Jul 29, 2026
Quantity
15,853 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Supernus Pharmaceuticals, Inc.

Original FDA data

Every field from FDA enforcement report D-0758-2026, exactly as published.

Show all FDA fields
City
Rockville
State
MD
Status
Ongoing
Country
United States
Event ID
99375
Address
9715 Key West Ave
Code information
Lot # 2075801, Exp Date: 31-Oct-2029.
Postal code
20850-3900
Report date
Jul 29, 2026
Product type
Drugs
Recall number
D-0758-2026
Classification
Class III
Recalling firm
Supernus Pharmaceuticals, Inc.
Product quantity
15,853 bottles
Reason for recall
Failed Dissolution Specifications
Voluntary / mandated
Voluntary: Firm initiated
Product description
Trokendi XR, topiramate extended-release capsules, 25mg, 30 Capsules, Rx only, Manufactured by: Catalent Pharma Solutions, Winchester, KY 40391 USA, Manufactured for: Supernus Pharmaceuticals, Inc., Rockville, MD 20850 USA, NDC 17772-101-30.
Distribution pattern
US Nationwide.
Recall initiation date
Jul 6, 2026
Initial firm notification
Letter
Center classification date
Aug 11, 2026

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0758-2026, published Jul 29, 2026. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls